Join
Live feed
·
INSIDERFilingvia Quantisnow
Windtree Therapeutics Inc. logo

President and CEO Fraser Craig bought $4,942 worth of shares (5,431 units at $0.91), increasing direct ownership by 169% to 8,638 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
WINT· Windtree Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WINT (Windtree Therapeutics Inc.) and more on Quantisnow.